Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04212533
Other study ID # hazem nour ca++
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 1, 2018
Est. completion date December 15, 2019

Study information

Verified date December 2019
Source Zagazig University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

two groups of patients undergoing total thyroidectomy one group received calcium and vit d prophylaxis the other group received no prophylaxis the investigator measured calcium level post and preoperative and development of tetant was recorded


Description:

This study is randomized controlled trial carried out on 86 patients undergoing total thyroidectomy in the period between January 2018 and November 2019. Patients were randomly allocated into two groups each one 43 patients the first group is the supplementation group where patients received oral vitamin D 40000 IU and calcium tablets 1 g once before surgery.

Patient included in this study are those above 18 years old undergoing total thyroidectomy.

Patients excluded from this study are those with

- Previous thyroid surgery

- Malabsorption diseases

- Pregnancy

- Previous parathyroid disease or surgery

- Vitamin D deficiency

- Renal impairment

- Hypo or hyper calcaemia

- ASA class 3,4

all patients in this study were subjected to thorough history taking full clinical examination, body mass index calculation, proper assessment of the original thyroid disease requiring surgery, preoperative investigations done as usual in addition to serum calcium, serum magnesium, serum vitamin D and serum parathormon level.

Serum calcium and serum parathormon were tested after 6, 12 and 48 postoperative hours, patients were discharged on the third postoperative day except if further hospitalization was indicated, after discharge patients were followed up in the outpatient clinic by one of the surgical team, serum calcium and parathormon level were tested after1 months, 3 months and after 6th months.

The primary outcome of this study is the development of hypocalcaemia either clinically or laboratory.

Clinical hypocalcaemia means development of perioral and \ or acral tingling and numbness, twitches of the perioral region on tapping in front of the ear" Chvostec's sign'', muscle twitches and development of carpopedal spasm.

Laboratory hypocalcaemia means serum calcium level below 8.5 mg\dl. Secondary outcome is the postoperative parathormon level. Preoperative data, postoperative clinical follow up and laboratory data were collected and analyzed using SPSS 22 program package.

Principles of total thyroidectomy; Total thyroidectomy was performed under general anesthesia, through lower neck collar incision, skin and platysma muscle flap was raised till the thyroid cartilage, opening the midline raphe, exploration of each thyroid lobe and tracing the inferior thyroid artery while emerging from underneath the carotid artery, the inferior thyroid artery was identified with its branches supplying the parathyroid gland, which was identified and preserved with its blood supply, the recurrent laryngeal nerve was searched for in the triangle between the carotid artery , trachea and the inferior thyroid artery. The external laryngeal nerve was identified and preserved 1 cm superior to the upper thyroid pole. If radical thyroidectomy was deemed the same principles of preserving parathyroid glands and their blood supply, recurrent and external laryngeal nerves. If the surgeons ere sure of damaging or removing the parathyroid glands a half of one of them was minced and transplanted in the subcutaneous tissue of the left forearm


Recruitment information / eligibility

Status Completed
Enrollment 86
Est. completion date December 15, 2019
Est. primary completion date December 15, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

• patient undergoing total thyroidectomy

Exclusion Criteria:

- Previous thyroid surgery

- Malabsorption diseases

- Pregnancy

- Previous parathyroid disease or surgery

- Vitamin D deficiency

- Renal impairment

- Hypo or hyper calcaemia

- ASA class 3,4

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Vitamin D
comparison between pre- and postoperative calcium and vitamin d level after vit d and calcium supplementation
rice starch tablets
rice starch tablets as placebo

Locations

Country Name City State
Egypt Zagazig Faculty of Medicine Zagazig Sharqya

Sponsors (1)

Lead Sponsor Collaborator
Zagazig University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary number of participants with hypocalcemia calcium level below 8.5 mg\dl measured by serum calcium assay 24 hrs post operative
Primary number of participants with hypocalcaemia calcium level below 8.5 mg\dl measured by serum calcium assay after 7 days post operative
Secondary number of participants with decreased parathormone level below normal level level of parathormone below 10 pg/mL ( 1st month post operative)
Secondary number of participants with tetany development of tingling, numbness or carpopedal spasm measured by clinical examination and patient history 1 week
See also
  Status Clinical Trial Phase
Completed NCT03276988 - Tolerability, Safety and Pharmacokinetics Study of GX-30 in Total Thyroidectomy or Near Total Thyroidectomy Patients Phase 1/Phase 2
Completed NCT02089542 - Intra-operative Infra-red Fluorescent Imaging in Thyroid and Parathyroid Surgery Phase 1/Phase 2
Recruiting NCT04012476 - Determination of Parathyroid Function by Fluorescence With Indocyanine Green (ICG) After Total Thyroidectomy Phase 4
Not yet recruiting NCT06383091 - Impact of Manual Therapy on Laryngeal Function Following Total Thyroidectomy N/A
Completed NCT02167529 - Quality of Life After Thyroidectomy (ThyrQol) N/A
Recruiting NCT05216419 - Prevention of Postoperative Hypocalcemia of Oral Vitamin D Supplementation Before Total Thyroidectomy Phase 4
Recruiting NCT06288750 - Protective Effect of Indocyanine Green Fluorescence Imaging Technology on Parathyroid Glands During Total Thyroidectomy N/A